Rodney Daniel Sinclair
The University of Melbourne · 849 works · 24,724 citations · h-index 77
Top works
- Summary of North American Hair Research Society (NAHRS)-sponsored Workshop on Cicatricial Alopecia, Duke University Medical Center, February 10 and 11, 2001
- Two Phase 3 Trials of Baricitinib for Alopecia Areata
- Development and validation of the International Hidradenitis Suppurativa Severity Score System ( IHS 4), a novel dynamic scoring system to assess HS severity
- Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials
- Incidence and prevalence of non‐melanoma skin cancer in A ustralia: A systematic review
- Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
- Prevalence of Male and Female Pattern Hair Loss in Maryborough
- Female pattern hair loss: a pilot study investigating combination therapy with low‐dose oral minoxidil and spironolactone
- The reliability of horizontally sectioned scalp biopsies in the diagnosis of chronic diffuse telogen hair loss in women
- Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis
- Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients
- Loss-of-function mutations of an inhibitory upstream ORF in the human hairless transcript cause Marie Unna hereditary hypotrichosis
- Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials
- Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
- Non‐melanoma skin cancer in Australia
- Treatment of female pattern hair loss with oral antiandrogens
- Androgenetic alopecia: pathogenesis and potential for therapy
- Male pattern androgenetic alopecia
- Diffuse hair loss
- Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors